The Pharmagellan Guide to Analyzing Biotech Clinical Trials

by Frank S. David

** Get info on bulk orders & how to get a free chapter at **

If you work in or around biotech, you’re supposed to understand clinical trial results. But what if you’re not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation.

The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.
If you're a biotech executive, investor, adviser, or entrepreneur -- or aspire to be one -- this handbook will give you the foundation you need to analyze clinical trials with more confidence.

Genres: Science, Finance, Health Care, Textbooks, Medicine, Biology

292 pages, Paperback

Published January 21, 2022

About the author

I'm a biopharma advisor at Pharmagellan who specializes in R&D strategy.

As an author, I want to help experts in and around the drug industry interpret clinical results and estimate the value of drugs in development.

Read my book ratings for my must-read recs for biopharma pros and newbies.

Please sign up for my free biotech newsletter on the Pharmagellan website!

Reviews

[Gunner Laine Hardy · Rating 5 out of 5]

Today marked my several month adventure reading this book outside of work and I have to say it’s a great read. Truly a raw presentation that is well structured yet still informative for various levels of understanding. You’ll probably have to read it twice, but I strongly recommend it.

[Jasvinder Banga · Rating 5 out of 5]

Provides great insights into clinical trials and its design.

[Chris · Rating 5 out of 5]

Good basics on trial design, phases, stats